India’s Bharat Biotech plans global launch for its oral cholera vaccine Hillchol
Technology tamfitronics Technology tamfitronics Story highlightsA report by the news agency Reuters said that Bharat Biotech's Hillchol would compete with South Korea's EuBiologics Co, which is the only WHO-approved producer of cholera vaccines.Indian biotechnology giant Bharat Biotech said on Tuesday (Aug 27) that its oral cholera vaccine Hillchol cleared a late-stage trial. Bharat Biotech said that India's drug regulator approved the vaccine, adding, it was now planning for a global launch.The company said it would apply for the World Health Organization's (WHO) pre-qualification to supply to major buyers like the UNICEF. A report by the news agency Reuters said that Hillchol would compete with South Korea's EuBiologics Co, which is the only WHO-approved producer of cholera vaccines.Technology tamfitronics A look at Bharat Biotech's plan for HillcholSpeaking to Reuters, Bharat Biotech said that its first intention was to help...